PATENT CLAIM ANALYSIS

Application Number: 16270291
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "476000"]

Abstract:
Disclosed are compounds of formulae: and pharmaceutically acceptable salts thereof, wherein the variables, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , n, and m are defined herein. These compounds are useful for treating Gram-negative bacteria infections. Also disclosed are methods of making these compounds.

Claim (Index 3):
A method of treating Gram-negative bacterial infections, the method comprising administering to a subject in need of such treatment an effective amount of a compound according to  claim 1 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.80851
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15681894', '13820404', '14912134', '14537048', '15179751']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.751836955978308
- 35 USC 102 Novelty (BERT): 0.6117914494520906
- Combined Prediction Score: 0.7378324053256863
- Mean Citation Score: 438.74352400000015
- Max Citation Score: 533.58167
- Similarity Product: 500.51905113809113

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test